Veronique Leblond - Assistance Publique – Hopitaux de Paris

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 390 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Alessandra Tedeschi,Constantine S. Tam,Roger G. Owen,Christian Buske,Veronique Leblond,Meletios Dimopoulos,Ramon Garcia-Sanz,Jorge J. Castillo,Judith Trotman,Steven P. Treon,Keri Yang,Boxiong Tang,Heather Allewelt,Sheel Patel,Wai Y. Chan,Aileen Cohen, Shengnan Chen,Gisoo Barnes

FUTURE ONCOLOGYno. 25 (2024): 1789-1798

引用0浏览0WOS引用

Open Label Non-Randomized Phase II Study Exploring «Chemo-Free » Treatment Association with Idelalisib + Obinutuzumab in Patients with Relapsed/Refractory (R/R) Waldenstrom's Macroglobulinemia (MW), a Filo Trial: Results of the Intermediary Analysis of the Induction Phase

Cécile Tomowiak,Stéphanie Poulain,Morgane Nudel, Pierre Feugier,Charles Herbaux,Béatrice Mahé,Pierre Morel,Thérèse Aurran,Olivier Tournilhac,Stéphane Leprêtre, Souad Assaad,Bruno Villemagne,Olivier Casasnovas, Adeline Lhermitte,Damien Roos-Weil, José Torregrosa-Diaz,Sylvie Chevret,Véronique Leblond

Annals of Hematology（2024）

引用7浏览0引用

Expert Opinion on Managing Adverse Reactions Associated with Acalabrutinib Therapy: A Delphi Consensus from France

Loïc Ysebaert, Stéphane Ederhy,Véronique Leblond, Stéphanie Malartre, Anaïs Portalier,Vincent Sibaud, Cécile Tomowiak, Jérémie Zerbit, Delphi Acalabrutinib Safety Study Group

Clinical lymphoma, myeloma & leukemia（2024）

引用0浏览0WOS引用

Biomarker Analysis of the ASPEN Study Comparing Zanubrutinib with Ibrutinib for Patients with Waldenström Macroglobulinemia

Constantine S. Tam,Stephen Opat,Shirley D'Sa,Wojciech Jurczak,Hui-Peng Lee,Gavin Cull,Roger G. Owen,Paula Marlton,Bjoern E. Wahlin,Ramon Garcia-Sanz,Helen McCarthy,Stephen Mulligan,Alessandra Tedeschi,Jorge J. Castillo,Jaros law Czyz,Carlos Fernandez De Larrea,David Belada,Edward Libby,Jeffrey Matous,Marina Motta,Tanya Siddiqi,Monica Tani,Marek Trneny,Monique C. Minnema, Christian Buske,Veronique Leblond,Steven P. Treon,Judith Trotman, Binghao Wu, Yiling Yu, Zhirong Shen, Wai Y. Chan, Jingjing Schneider,Heather Allewelt,Aileen Cohen,Meletios A. Dimopoulos

Blood advancesno. 7 (2024): 1639-1650

引用0浏览0WOS引用

Circulating Tumor Cells in Waldenström Macroglobulinemia

Clémentine Boccon-Gibod,Elise Sourdeau,Pierre Morel,Elise Chapiro,Florence Nguyen-Khac,Clotilde Bravetti,Frédéric Davi,Véronique Morel,Nicolas Gauthier,Adrien Grenier,Inès Boussen,Sylvain Choquet,Véronique Leblond,Magali Le Garff-Tavernier,Marine Baron,Damien Roos-Weil

Leukemiapp.1-5, (2024)

引用0浏览0WOSNATURE引用

Long-term Results of Waldenström Macroglobulinaemia Treatment by Bendamustine and Rituximab: A Study on Behalf of the French Innovative Leukemia Organization (FILO)

Kamel Laribi,Stephanie Poulain,Lise Willems,Fatiha Merabet,Charles Herbaux,Damien Roos-Weil, Ines Laribi de Materre,Xavier Roussel,Morgane Nudel,Sabine Tricot,Jehan Dupuis,Ronan Le Calloch,Benoit Bareau,Veronique Leblond

BRITISH JOURNAL OF HAEMATOLOGYno. 6 (2024): 2233-2236

引用0浏览0WOS引用

Prognostic Impact of Genetic Abnormalities in 536 First‐line Chronic Lymphocytic Leukaemia Patients Without 17p Deletion Treated with Chemoimmunotherapy in Two Prospective Trials: Focus on IGHV‐mutated Subgroups (a FILO Study)

Florence Nguyen-Khac,Marine Baron,Romain Guieze,Pierre Feugier, Alexandra Fayault,Sophie Raynaud,Xavier Troussard,Nathalie Droin,Frederik Damm,Luce Smagghe,Santos Susin,Veronique Leblond,Caroline Dartigeas,Eric Van den Neste,Stephane Lepretre,Olivier A. Bernard,Damien Roos-Weil

BRITISH JOURNAL OF HAEMATOLOGYno. 2 (2024): 495-502

引用0浏览0WOS引用

Neurolymphomatosis: Involvement of Peripheral Nervous System Revealing Hematologic Malignancy, a Report of Nine Cases

Pauline Ducatel,Maud Michaud,Karine Viala,Veronique Leblond,Frederic Charlotte,Damien Roos-Weil,Charline Benoit,Rabab Debs,Thierry Maisonobe

Journal of the peripheral nervous systemno. 2 (2023): 252-261

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn